Metraipolis › archive › dc_f4cfe424a8cb

Reassessing the risk-modifying effects of novel antidiabetic agents on asthma-COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults… — Europe PMC PMID:42376494

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42376494
DOI
10.1016/j.eclinm.2026.104026
License (as archived)
solo-consultazione
Archived
2026-10-19T07:43:54.813Z
SHA-256 of the archived text
6e041d53835038da56d4a3b02b5e261aae1f314863a0343c0e7ddf405718e8d1
Stable URL of this page
https://metraipolis.com/documento/dc_f4cfe424a8cb

How to cite

Reassessing the risk-modifying effects of novel antidiabetic agents on asthma-COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults… — Europe PMC PMID:42376494 — Europe PMC (en), https://europepmc.org/article/MED/42376494 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f4cfe424a8cb (Metraipolis archive dc_f4cfe424a8cb, sha256 6e041d53835038da56d4a3b02b5e261aae1f314863a0343c0e7ddf405718e8d1)
BibTeX
@misc{dcf4cfe424a8cb,
  title = {Reassessing the risk-modifying effects of novel antidiabetic agents on asthma-COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults… — Europe PMC PMID:42376494},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42376494},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f4cfe424a8cb; sha256 6e041d53835038da56d4a3b02b5e261aae1f314863a0343c0e7ddf405718e8d1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42376494. Agents can read the archived copy with the MCP tool read_document.